BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37719722)

  • 1. International practices in health technology assessment and public financing of digital health technologies: recommendations for Hungary.
    Mezei F; Horváth K; Pálfi M; Lovas K; Ádám I; Túri G
    Front Public Health; 2023; 11():1197949. PubMed ID: 37719722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Value of Provider-Facing Digital Health Technologies Used in Chronic Disease Management: Toward a Value Framework Based on Multistakeholder Perceptions.
    Main C; Haig M; Chavez D; Kanavos P
    Med Decis Making; 2024 Jan; 44(1):28-41. PubMed ID: 37882333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons for Vietnam on the Use of Digital Technologies to Support Patient-Centered Care in Low- and Middle-Income Countries in the Asia-Pacific Region: Scoping Review.
    Kosowicz L; Tran K; Khanh TT; Dang TH; Pham VA; Ta Thi Kim H; Thi Bach Duong H; Nguyen TD; Phuong AT; Le TH; Ta VA; Wickramasinghe N; Schofield P; Zelcer J; Pham Le T; Nguyen TA
    J Med Internet Res; 2023 Apr; 25():e43224. PubMed ID: 37018013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?
    Kovács S; Németh B; Erdősi D; Brodszky V; Boncz I; Kaló Z; Zemplényi A
    Appl Health Econ Health Policy; 2022 May; 20(3):291-303. PubMed ID: 35041177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Digital Therapeutics on Current Health Technology Assessment Frameworks.
    Yan K; Balijepalli C; Druyts E
    Front Digit Health; 2021; 3():667016. PubMed ID: 34713140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
    Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
    Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health technology assessment for digital technologies that manage chronic disease: a systematic review.
    von Huben A; Howell M; Howard K; Carrello J; Norris S
    Int J Technol Assess Health Care; 2021 May; 37(1):e66. PubMed ID: 34034851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Institute for Clinical and Economic Review - Peterson Health Technology Institute value assessment framework for digital health technologies.
    Pearson SD; Singh P; Beaudoin F; Campbell J; Schapiro L; Emond SK; Pearson C
    J Comp Eff Res; 2023 Dec; 12(12):e230154. PubMed ID: 37965898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the National Institute for Health and Care Excellence Evidence Standards Framework for Digital Health Technologies in Assessing Mobile-Delivered Technologies for the Self-Management of Type 2 Diabetes Mellitus: Scoping Review.
    Forsyth JR; Chase H; Roberts NW; Armitage LC; Farmer AJ
    JMIR Diabetes; 2021 Feb; 6(1):e23687. PubMed ID: 33591278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries.
    Kolasa K; Kalo Z; Zah V; Dolezal T
    Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):283-7. PubMed ID: 22812552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping.
    van Kessel R; Srivastava D; Kyriopoulos I; Monti G; Novillo-Ortiz D; Milman R; Zhang-Czabanowski WW; Nasi G; Stern AD; Wharton G; Mossialos E
    JMIR Mhealth Uhealth; 2023 Sep; 11():e49003. PubMed ID: 37773610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating environmental considerations in digital health technology assessment and procurement: Stakeholders' perspectives.
    Alami H; Rivard L; Lehoux P; Ag Ahmed MA; Fortin JP; Fleet R
    Digit Health; 2023; 9():20552076231219113. PubMed ID: 38074337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study.
    Jenei K; Raymakers AJN; Bayle A; Berger-Thürmel K; Cherla A; Honda K; Jackson CCGA; Karikios D; Trapani D; Berry S; Gyawali B
    Lancet Oncol; 2023 Jun; 24(6):624-635. PubMed ID: 37269843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OVERVIEW ON THE CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN THE HEALTHCARE SYSTEM IN HUNGARY.
    Németh B; Csanádi M; Kaló Z
    Int J Technol Assess Health Care; 2017 Jan; 33(3):333-338. PubMed ID: 28434433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological Frameworks and Dimensions to Be Considered in Digital Health Technology Assessment: Scoping Review and Thematic Analysis.
    Segur-Ferrer J; Moltó-Puigmartí C; Pastells-Peiró R; Vivanco-Hidalgo RM
    J Med Internet Res; 2024 Apr; 26():e48694. PubMed ID: 38598288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [E-health developments in the system of health services in Hungary and the European Union].
    Váradi Á
    Orv Hetil; 2014 May; 155(21):822-7. PubMed ID: 24836317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a health technology assessment framework to digital health technologies that manage chronic disease: a systematic review.
    von Huben A; Howell M; Carrello J; Norris S; Wortley S; Ritchie A; Howard K
    Int J Technol Assess Health Care; 2021 Dec; 38(1):e9. PubMed ID: 34924061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capacity Building for HTA Implementation in Middle-Income Countries: The Case of Hungary.
    Kaló Z; Bodrogi J; Boncz I; Dózsa C; Jóna G; Kövi R; Pásztélyi Z; Sinkovits B;
    Value Health Reg Issues; 2013; 2(2):264-266. PubMed ID: 29702875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technology assessment of digital health applications for reimbursement decisions].
    Jeindl R; Wild C
    Wien Med Wochenschr; 2024 Mar; 174(3-4):44-52. PubMed ID: 34529150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union.
    Beletsi A; Koutrafouri V; Karampli E; Pavi E
    Value Health Reg Issues; 2018 Sep; 16():81-91. PubMed ID: 30316029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.